Development of neuroactive steroids for the treatment of postpartum depression von Gunduz‐Bruce, Handan, Takahashi, Koji, Huang, Ming‐Yi

Volltext

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults von Bullock, Amy, Gunduz‐Bruce, Handan, Zammit, Gary K., Qin, Min, Li, Haihong, Sankoh, Abdul J., Silber, Christopher, Kanes, Stephen J., Jonas, Jeffrey, Doherty, James

Volltext

Trial of SAGE-217 in Patients with Major Depressive Disorder von Gunduz-Bruce, Handan, Silber, Christopher, Kaul, Inder, Rothschild, Anthony J, Riesenberg, Robert, Sankoh, Abdul J, Li, Haihong, Lasser, Robert, Zorumski, Charles F, Rubinow, David R, Paul, Steven M, Jonas, Jeffrey, Doherty, James J, Kanes, Stephen J

Volltext

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial von Kanes, Stephen, MD, Colquhoun, Helen, MD, Gunduz-Bruce, Handan, MD, Raines, Shane, Arnold, Ryan, DO, Schacterle, Amy, PhD, Doherty, James, PhD, Epperson, C Neill, Prof, Deligiannidis, Kristina M, MD, Riesenberg, Robert, MD, Hoffmann, Ethan, Rubinow, David, Prof, Jonas, Jeffrey, MD, Paul, Steven, MD, Meltzer-Brody, Samantha, Dr

Volltext

The acute effects of NMDA antagonism: From the rodent to the human brain von Gunduz-Bruce, Handan

Volltext

The effect of pre‐existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center von Wadia, Roxanne J., Yao, Xiaopan, Deng, Yanhong, Li, Jia, Maron, Steven, Connery, Donna, Gunduz‐Bruce, Handan, Rose, Michal G.

Volltext

Role of N -Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia von Kort, Naomi S, Ford, Judith M, Roach, Brian J, Gunduz-Bruce, Handan, Krystal, John H, Jaeger, Judith, Reinhart, Robert M.G, Mathalon, Daniel H

Volltext

Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists von Krystal, John H., Mathew, Sanjay J., D’Souza, D. Cyril, Garakani, Amir, Gunduz-Bruce, Handan, Charney, Dennis S.

Volltext

Clinical and Neuropsychological Correlates of White Matter Abnormalities in Recent Onset Schizophrenia von Szeszko, Philip R, Robinson, Delbert G, Ashtari, Manzar, Vogel, Joshua, Betensky, Julia, Sevy, Serge, Ardekani, Babak A, Lencz, Todd, Malhotra, Anil K, McCormack, Joanne, Miller, Rachel, Lim, Kelvin O, Gunduz-Bruce, Handan, Kane, John M, Bilder, Robert M

Volltext

A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia von Gunduz‐Bruce, Handan, Kenney, Joshua, Changlani, Suravi, Peixoto, Aldo, Gueorguieva, Ralitza, Leone, Cheryl, Stachenfeld, Nina

Volltext

Mapping Cortical Thickness and Gray Matter Concentration in First Episode Schizophrenia von Narr, Katherine L., Bilder, Robert M., Toga, Arthur W., Woods, Roger P., Rex, David E., Szeszko, Philip R., Robinson, Delbert, Sevy, Serge, Gunduz-Bruce, Handan, Wang, Yung-Ping, DeLuca, Heather, Thompson, Paul M.

Volltext

Glutamatergic Modulation of Auditory Information Processing in the Human Brain von Gunduz-Bruce, Handan, Reinhart, Robert M.G, Roach, Brian J, Gueorguieva, Ralitza, Oliver, Stephen, D'Souza, Deepak C, Ford, Judith M, Krystal, John H, Mathalon, Daniel H

Volltext

DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients von Lencz, Todd, Robinson, Delbert G., Xu, Ke, Ekholm, Jenny, Sevy, Serge, Gunduz-Bruce, Handan, Woerner, Margaret G., Kane, John M., Goldman, David, Malhotra, Anil K.

Volltext

Volumetric and shape analysis of the thalamus in first-episode schizophrenia von Coscia, Denise M., Narr, Katherine L., Robinson, Delbert G., Hamilton, Liberty S., Sevy, Serge, Burdick, Katherine E., Gunduz-Bruce, Handan, McCormack, Joanne, Bilder, Robert M., Szeszko, Philip R.

Volltext

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial von Deligiannidis, Kristina M, Meltzer-Brody, Samantha, Gunduz-Bruce, Handan, Doherty, James, Jonas, Jeffrey, Li, Sigui, Sankoh, Abdul J, Silber, Christopher, Campbell, Andrew D, Werneburg, Brian, Kanes, Stephen J, Lasser, Robert

Volltext

Trial of SAGE-217 in Patients with Major Depressive Disorder. Reply von Gunduz-Bruce, Handan, Kanes, Stephen J, Zorumski, Charles F

Volltext

Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder von Suthoff, Ellison, Kosinski, Mark, Arnaud, Alix, Hodgkins, Paul, Gunduz-Bruce, Handan, Lasser, Robert, Silber, Christopher, Sankoh, Abdul J., Li, Haihong, Werneburg, Brian, Jonas, Jeffrey, Doherty, James, Kanes, Stephen J., Bonthapally, Vijayveer

Volltext

Trial of SAGE-217 in Patients with Major Depressive Disorder von Rosenblat, Joshua D, Gunduz-Bruce, Handan, Kanes, Stephen J, Zorumski, Charles F

Volltext

Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia von SZESZKO, Philip R, NARR, Katherine L, PHILLIPS, Owen R, MCCORMACK, Joanne, SEVY, Serge, GUNDUZ-BRUCE, Handan, KANE, John M, BILDER, Robert M, ROBINSON, Delbert G

Volltext

Insights on GABAergic Mechanism of PPD from Pivotal Studies of Brexanolone Injection and SAGE-217 [18E] von Meltzer-Brody, Samantha, Deligiannidis, Kristina, Colquhoun, Helen, Gunduz-Bruce, Handan, Dray, Danielle, Kanes, Stephen

Volltext